KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Ayesha M. Lau
Partner in charge, Tax - HK SAR
+852 2826 8028
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
This straightforward and accessible guide is co-authored by Ayesha M. Lau and Garry Laird of KPMG China's Hong Kong office.